Press release
Bronchitis Treatment Market 2034: Market Size, Competitive Landscape, Companies, Clinical Trials, FDA Aprrovasls and Future Outlook by DelveInsight
Bronchitis Treatment Market
DelveInsight's "Bronchitis Market Insights, Epidemiology, and Market Forecast-2034" report provides a comprehensive analysis of Bronchitis, covering historical and projected epidemiology, as well as market trends across the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Explore critical insights from DelveInsight's detailed Bronchitis market analysis @ Bronchitis Market Size - https://www.delveinsight.com/report-store/bronchitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Key Highlights from the Bronchitis Market Report
• February 2025 - Chiesi Farmaceutici S.p.A.: Initiated a 52-week, randomized, double-blind, placebo- and active-controlled trial evaluating two doses of CHF6001 DPI as an add-on to maintenance triple therapy in patients with COPD and chronic bronchitis.
• February 2025 - Deciphera Pharmaceuticals Inc.: Launched a study assessing the safety, tolerability, and efficacy of vimseltinib in adults with active moderate to severe cGVHD, with participants undergoing 28-day treatment cycles for approximately two years.
• In 2022, the 7MM reported 19.5 million pediatric and 29.1 million adult cases of acute bronchitis, with numbers expected to increase throughout the forecast period.
• Japan represented the lowest share of chronic bronchitis cases in the 7MM, contributing roughly 4% of the total burden.
• Germany recorded 1.57 million pediatric and 2.82 million adult acute bronchitis cases in 2022, both projected to grow.
• Across the 7MM, there were 26.95 million chronic bronchitis cases in 2022, anticipated to rise by 2032.
• Among the EU4 and the UK, France and the UK reported the highest number of acute bronchitis cases, comprising 47% of all such cases in these regions in 2022.
• Leading companies in the Bronchitis landscape include Hanlim Pharm., Ahn-Gook Pharmaceuticals, PharmaKing, Johnson & Johnson, Yuhan Corporation, Korea United Pharm., Hyundai Pharmaceutical, Bayer, Wake Forest University, Pfizer, Sanofi, Pharmaxis, EmeraMed, Abgenix, and others.
• Key therapies in development or use include HL301, AGS, N02RS1, levofloxacin, YHD001, KALOMINTM, Acebrophylline, Synatura®, Avelox (Moxifloxacin), Oral NAC, Moxifloxacin, telithromycin, TPI 1020, Emeramide, ABX-IL8, and more.
Stay informed on Bronchitis therapeutic advancements with DelveInsight @ Bronchitis Market Outlook - https://www.delveinsight.com/report-store/bronchitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Bronchitis Overview
Bronchitis is an inflammatory condition of the bronchial tubes that carry air to and from the lungs. It presents in two main forms: acute bronchitis, typically caused by viral infections and characterized by short-term cough and mucus production, and chronic bronchitis, a long-term condition often linked to smoking and classified under COPD. Symptoms commonly include persistent cough, chest discomfort, fatigue, and breathing difficulties. Acute cases usually resolve within weeks, while chronic bronchitis involves ongoing airway inflammation and frequent exacerbations. Early diagnosis, lifestyle modification, and appropriate therapies are essential to managing disease progression and improving patient quality of life.
Bronchitis Epidemiology Segmentation (7MM)
• Overall Bronchitis prevalence
• Prevalence by severity
• Gender-specific prevalence
• Diagnosed episodic vs. chronic bronchitis cases
Download the full report for detailed epidemiology trends @ Bronchitis Prevalence - https://www.delveinsight.com/report-store/bronchitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Bronchitis Competitive Landscape
The Bronchitis market report evaluates uptake patterns of recently launched and upcoming Bronchitis therapies, analyzing patient adoption rates, individual drug sales, comparative market share, and factors influencing rapid uptake. It also assesses current and emerging therapeutics across the competitive landscape.
Key Bronchitis Therapies and Developers
• HL301 - Hanlim Pharm.
• AGS - Ahn-Gook Pharmaceuticals
• N02RS1 - PharmaKing
• Levofloxacin - Johnson & Johnson
• YHD001 - Yuhan Corporation
• KALOMINTM - Korea United Pharm.
• Acebrophylline - Hyundai Pharmaceutical
• Synatura® - Ahn-Gook Pharma
• Avelox (Moxifloxacin) - Bayer
• Oral NAC - Wake Forest University
• Moxifloxacin - Pfizer
• Telithromycin - Sanofi
• TPI 1020 - Pharmaxis
• Emeramide - EmeraMed
• ABX-IL8 - Abgenix
Gain comprehensive insights into market trends and forecasts @ Bronchitis Treatment Market - https://www.delveinsight.com/report-store/bronchitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Scope of the Bronchitis Market Report
• Study Period: 2020-2034
• Geographical Coverage: 7MM
• Companies Assessed: Hanlim Pharm., Ahn-Gook Pharmaceuticals, PharmaKing, Johnson & Johnson, Yuhan Corporation, Korea United Pharm., Hyundai Pharmaceutical, Bayer, Pfizer, Sanofi, Pharmaxis, EmeraMed, Abgenix, etc.
• Therapies Covered: HL301, AGS, N02RS1, levofloxacin, YHD001, KALOMINTM, Acebrophylline, Synatura®, Avelox, NAC, Moxifloxacin, telithromycin, TPI 1020, Emeramide, ABX-IL8
• Assessment Areas: Marketed and emerging therapies, market drivers and barriers, competitive intelligence (SWOT, PESTLE, Porter's Five Forces, BCG Matrix, market entry strategies), unmet needs, KOL insights, analyst viewpoints, market access, and reimbursement landscape
Unlock deep market understanding @ Bronchitis Market Drivers and Barriers - https://www.delveinsight.com/report-store/bronchitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Contents
1. Bronchitis Market Report Introduction
2. Executive Summary for Bronchitis
3. SWOT analysis of Bronchitis
4. Bronchitis Patient Share (%) Overview at a Glance
5. Bronchitis Market Overview at a Glance
6. Bronchitis Disease Background and Overview
7. Bronchitis Epidemiology and Patient Population
8. Country-Specific Patient Population of Bronchitis
9. Bronchitis Current Treatment and Medical Practices
10. Bronchitis Unmet Needs
11. Bronchitis Emerging Therapies
12. Bronchitis Market Outlook
13. Country-Wise Bronchitis Market Analysis (2019-2032)
14. Bronchitis Market Access and Reimbursement of Therapies
15. Bronchitis Market Drivers
16. Bronchitis Market Barriers
17. Bronchitis Appendix
18. Bronchitis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bronchitis Treatment Market 2034: Market Size, Competitive Landscape, Companies, Clinical Trials, FDA Aprrovasls and Future Outlook by DelveInsight here
News-ID: 4276729 • Views: …
More Releases from DelveInsight Business Research
Asthma Market is projected to grow at a CAGR of 1.9% During 2024-2034, Estimates …
DelveInsight's "Asthma Market Insights, Epidemiology, and Market Forecast - 2034" report offers a comprehensive analysis of asthma, including historical and projected epidemiology, along with market trends across the United States, EU4 (Germany, France, Italy, Spain), the United Kingdom, and Japan.
Explore detailed insights into the evolving Asthma Market here: Asthma Market Size - https://www.delveinsight.com/report-store/asthma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Key Highlights from the Asthma Market Report
• February 2025 - Areteia Therapeutics: Ongoing study evaluating the efficacy and…
Global Endovascular Aneurysm Repair Devices Market Size to grow at a CAGR of 5.8 …
According to DelveInsight's analysis, the increasing prevalence of abdominal and thoracic aortic aneurysms (AAA and TAA) is a major driver of the Endovascular Aneurysm Repair (EVAR) market. With a growing aging population, there is rising demand for minimally invasive treatments like EVAR, which offer benefits such as shorter hospital stays, fewer complications, and faster recovery compared to traditional surgery. Moreover, ongoing technological advancements in EVAR devices such as more flexible…
Global Cardiac Mapping System Market Size to grow at a CAGR of 8.37% by 2032, Ev …
According to DelveInsight's analysis, The growing prevalence of cardiac arrhythmias, including atrial fibrillation and ventricular tachycardia, is driving the expansion of the cardiac mapping system market. These systems are crucial for early diagnosis and treatment, providing real-time visualization of the heart's electrical activity to prevent serious complications such as stroke and heart failure. Moreover, the increasing adoption of minimally invasive procedures like catheter ablation, which rely heavily on advanced mapping…
Global Male Infertility Market Size to grow at a CAGR of 3.42% to reach USD 5,00 …
According to DelveInsight's analysis, The global male infertility treatments market is being significantly driven by the rising prevalence of male infertility, caused by lifestyle disorders, structural abnormalities, genetic factors, and other underlying conditions. Increased awareness and greater social acceptance have helped reduce stigma, motivating more men to seek medical care. Advancements in diagnostic technologies, including genetic testing and advanced imaging, alongside innovative treatments such as hormonal therapies and minimally invasive…
More Releases for Bronchitis
Rising Respiratory Disease Incidence Sparks Robust Growth In Bronchitis Treatmen …
The Bronchitis Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Bronchitis Treatment Market?
The market for bronchitis treatments has seen robust expansion in the past few years, with projections showing an increase from $5.61 billion in 2024 to…
Acute Bronchitis Treatment Market: An In-Depth Analysis
The global Acute Bronchitis Treatment market was valued at approximately USD 6.3 billion in 2023 and is projected to reach around USD 9.9 billion by 2031, exhibiting a compound annual growth rate (CAGR) of 5.3% during the forecast period.
Acute Bronchitis Treatment Market Overview
Acute bronchitis is a common respiratory condition characterized by inflammation of the bronchial tubes, leading to symptoms such as coughing and mucus production. The market's growth…
Bronchitis Treatment Market Statistical Forecast, Trade Analysis 2024 - 2031
DataM Intelligence has published a new research report on "Bronchitis Treatment Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Free Sample Research PDF -…
Bronchitis Treatment Market Outlook, Insights, Size 2024-2033
The bronchitis treatment market size has grown strongly in recent years. It will grow from $5.25 billion in 2023 to $5.58 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to rising air pollution levels, cigarette smoking epidemic, increased respiratory infections, environmental and occupational exposures, lifestyle factors..
The bronchitis treatment market size is expected to see strong…
Acute Bronchitis Treatment Market: What are the key opportunities?
The report attempts to offer high-quality and accurate analysis of the global Acute Bronchitis Treatment Market, keeping in view market forecasts, competitive intelligence, and technological risks and advancements, and other important subjects. Its carefully crafted market intelligence allows market participants to understand the most significant developments in the global Acute Bronchitis Treatment market that are impacting their business. Readers can become aware of crucial opportunities available in the global Acute…
Bronchitis Market: Study Navigating the Future Growth Outlook
Global Bronchitis Market Report 2019 - Market Size, Share, Price, Trend and Forecast is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the Global Bronchitis Market. Some of the key players profiled in the study are…
